Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome

Andersen-Tawil Syndrome (ATS) is a rare disease defined by the association of cardiac arrhythmias, periodic paralysis and dysmorphic features, and is caused by KCNJ2 loss-of-function mutations. However, when extracardiac symptoms are atypical or absent, the patient can be diagnosed with Catecholamin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pauline Le Tanno, Mathilde Folacci, Jean Revilloud, Laurence Faivre, Gabriel Laurent, Lucile Pinson, Pascal Amedro, Gilles Millat, Alexandre Janin, Michel Vivaudou, Nathalie Roux-Buisson, Julien Fauré
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/1eea676b9315439d98a82f282c9786d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1eea676b9315439d98a82f282c9786d4
record_format dspace
spelling oai:doaj.org-article:1eea676b9315439d98a82f282c9786d42021-12-01T01:12:23ZCharacterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome1664-802110.3389/fgene.2021.773177https://doaj.org/article/1eea676b9315439d98a82f282c9786d42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.773177/fullhttps://doaj.org/toc/1664-8021Andersen-Tawil Syndrome (ATS) is a rare disease defined by the association of cardiac arrhythmias, periodic paralysis and dysmorphic features, and is caused by KCNJ2 loss-of-function mutations. However, when extracardiac symptoms are atypical or absent, the patient can be diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), a rare arrhythmia at high risk of sudden death, mostly due to RYR2 mutations. The identification of KCNJ2 variants in CPVT suspicion is very rare but important because beta blockers, the cornerstone of CPVT therapy, could be less efficient. We report here the cases of two patients addressed for CPVT-like phenotypes. Genetic investigations led to the identification of p. Arg82Trp and p. Pro186Gln de novo variants in the KCNJ2 gene. Functional studies showed that both variants forms of Kir2.1 monomers act as dominant negative and drastically reduced the activity of the tetrameric channel. We characterize here a new pathogenic variant (p.Pro186Gln) of KCNJ2 gene and highlight the interest of accurate cardiologic evaluation and of attention to extracardiac signs to distinguish CPVT from atypical ATS, and guide therapeutic decisions. We also confirm that the KCNJ2 gene must be investigated during CPVT molecular analysis.Pauline Le TannoMathilde FolacciJean RevilloudLaurence FaivreGabriel LaurentLucile PinsonLucile PinsonLucile PinsonPascal AmedroGilles MillatAlexandre JaninMichel VivaudouNathalie Roux-BuissonJulien FauréFrontiers Media S.A.articlecatecholaminergic polymorphic ventricular tachycardiaAndersen-Tawil syndromeKir2.1 channelPierre Robin sequencefunctionnal characterizationKCNJ2 variantsGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic catecholaminergic polymorphic ventricular tachycardia
Andersen-Tawil syndrome
Kir2.1 channel
Pierre Robin sequence
functionnal characterization
KCNJ2 variants
Genetics
QH426-470
spellingShingle catecholaminergic polymorphic ventricular tachycardia
Andersen-Tawil syndrome
Kir2.1 channel
Pierre Robin sequence
functionnal characterization
KCNJ2 variants
Genetics
QH426-470
Pauline Le Tanno
Mathilde Folacci
Jean Revilloud
Laurence Faivre
Gabriel Laurent
Lucile Pinson
Lucile Pinson
Lucile Pinson
Pascal Amedro
Gilles Millat
Alexandre Janin
Michel Vivaudou
Nathalie Roux-Buisson
Julien Fauré
Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
description Andersen-Tawil Syndrome (ATS) is a rare disease defined by the association of cardiac arrhythmias, periodic paralysis and dysmorphic features, and is caused by KCNJ2 loss-of-function mutations. However, when extracardiac symptoms are atypical or absent, the patient can be diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), a rare arrhythmia at high risk of sudden death, mostly due to RYR2 mutations. The identification of KCNJ2 variants in CPVT suspicion is very rare but important because beta blockers, the cornerstone of CPVT therapy, could be less efficient. We report here the cases of two patients addressed for CPVT-like phenotypes. Genetic investigations led to the identification of p. Arg82Trp and p. Pro186Gln de novo variants in the KCNJ2 gene. Functional studies showed that both variants forms of Kir2.1 monomers act as dominant negative and drastically reduced the activity of the tetrameric channel. We characterize here a new pathogenic variant (p.Pro186Gln) of KCNJ2 gene and highlight the interest of accurate cardiologic evaluation and of attention to extracardiac signs to distinguish CPVT from atypical ATS, and guide therapeutic decisions. We also confirm that the KCNJ2 gene must be investigated during CPVT molecular analysis.
format article
author Pauline Le Tanno
Mathilde Folacci
Jean Revilloud
Laurence Faivre
Gabriel Laurent
Lucile Pinson
Lucile Pinson
Lucile Pinson
Pascal Amedro
Gilles Millat
Alexandre Janin
Michel Vivaudou
Nathalie Roux-Buisson
Julien Fauré
author_facet Pauline Le Tanno
Mathilde Folacci
Jean Revilloud
Laurence Faivre
Gabriel Laurent
Lucile Pinson
Lucile Pinson
Lucile Pinson
Pascal Amedro
Gilles Millat
Alexandre Janin
Michel Vivaudou
Nathalie Roux-Buisson
Julien Fauré
author_sort Pauline Le Tanno
title Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
title_short Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
title_full Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
title_fullStr Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
title_full_unstemmed Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome
title_sort characterization of loss-of-function kcnj2 mutations in atypical andersen tawil syndrome
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/1eea676b9315439d98a82f282c9786d4
work_keys_str_mv AT paulineletanno characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT mathildefolacci characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT jeanrevilloud characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT laurencefaivre characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT gabriellaurent characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT lucilepinson characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT lucilepinson characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT lucilepinson characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT pascalamedro characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT gillesmillat characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT alexandrejanin characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT michelvivaudou characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT nathalierouxbuisson characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
AT julienfaure characterizationoflossoffunctionkcnj2mutationsinatypicalandersentawilsyndrome
_version_ 1718406008576933888